3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
21
Glioblastoma
5
Breast Neoplasms
5
Neoplasms
4
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Leukoplakia, Oral
3
Insulin Resistance
3
Metabolic Syndrome
2
Metabolic Diseases
2
Medulloblastoma
2
Infertility
2
Erythroplasia
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Intraductal, Noninfiltrating
2
Adenocarcinoma Of Esophagus
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Thyroid Diseases
1
TP53 Y220C Mutation
1
Smoldering Multiple Myeloma
1
Sarcoma
1
Rectal Neoplasms
1
Prostate Cancer Recurrent
1
Prediabetic State
1
Posterior Fossa Ependymal Tumor
1
Pleural Effusion, Malignant
1
Pathologic Complete Response
1
Interventions
Rituximab
45
Cyclophosphamide
32
Lenalidomide
24
fludarabine
20
zanubrutinib
14
venetoclax
12
obinutuzumab
12
orelabrutinib
11
fludarabine phosphate
10
Magnetic Resonance Spectroscopy
10
Bendamustine Hydrochloride
10
Whole-Body Irradiation
8
Specimen Handling
8
Prednisone
8
pirtobrutinib
7
ibrutinib
7
Vincristine
7
CT-P10
7
Biopsy
7
Mycophenolic Acid
6
Doxorubicin
5
tafasitamab
4
polatuzumab vedotin
3
pembrolizumab
3
acalabrutinib
3
Tacrolimus
3
Sirolimus
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Nivolumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Metformin
×
1 year
×
Clear all
No trials found.